Authors:
HERMAN P
FERRANT A
DEBRUYERE M
STRAETMANS N
Citation: P. Herman et al., STROMAL FACTORS SUPPORT THE EXPANSION OF THE WHOLE HEMATOPOIETIC SPECTRUM FROM BONE-MARROW CD34(-) CELLS AND OF SOME HEMATOPOIETIC SUBSETS FROM CD34(+) AND CD34(+)DR(+) CELLS()DR(), Leukemia, 12(5), 1998, pp. 735-745
Authors:
HERMAN P
FERRANT A
DEBRUYERE M
STRAETMANS N
Citation: P. Herman et al., EFFECTS OF HIGH-DOSES OF STEM-CELL FACTOR AND FLT3-LIGAND ON CD34-LEUKEMIA IN FIRST-REMISSION (CR-1 AML)( CELLS FROM ACUTE MYELOID), British Journal of Haematology, 102(1), 1998, pp. 71-71
Authors:
MORSCHHAUSER F
CAYUELA JM
MARTINI S
BARUCHEL A
ROUSSELOT P
SOCIE G
JOUET JP
STRAETMANS N
MARTIAT P
FENAUX P
PREUDHOMME C
Citation: F. Morschhauser et al., EVALUATION OF MINIMAL RESIDUAL DISEASE USING RT-PCR IN 37 T(8,21) AMLPATIENTS, British Journal of Haematology, 102(1), 1998, pp. 99-99
Authors:
STRAETMANS N
HERMAN P
VANBOCKSTAELE DR
MICHAUX L
HAGEMEIJER A
FERRANT A
Citation: N. Straetmans et al., HEMATOPOIETIC DEFECT AND DECREASED EXPANSION POTENTIAL OF BONE-MARROWAUTOGRAFTS FROM PATIENTS WITH ACUTE MYELOID-LEUKEMIA IN FIRST REMISSION, British Journal of Haematology, 101(3), 1998, pp. 571-581
Authors:
BRICE P
BASTION Y
LEPAGE E
BROUSSE N
HAIOUN C
MOREAU P
STRAETMANS N
TILLY H
TABAH I
SOLALCELIGNY P
Citation: P. Brice et al., COMPARISON IN LOW-TUMOR-BURDEN FOLLICULAR LYMPHOMAS BETWEEN AN INITIAL NO-TREATMENT POLICY, PREDNIMUSTINE, OR INTERFERON-ALFA - A RANDOMIZED STUDY FROM THE GROUPE-DETUDE-DES-LYMPHOMES-FOLLICULAIRES, Journal of clinical oncology, 15(3), 1997, pp. 1110-1117
Authors:
HERMAN P
FERRANT A
VANBOCKSTAELE DR
MICHAUX JL
DEBRUYERE M
STRAETMANS N
Citation: P. Herman et al., EX-VIVO EXPANSION OF CD34-MARROW (BM) OF AML IN FIRST REMISSION IS IMPROVED BY EXPOSURE TO HIGH-CONCENTRATIONS OF STEM-CELL FACTOR AND FLT3-LIGAND( CELLS FROM BONE), Blood, 90(10), 1997, pp. 4286-4286
Authors:
LECOUVET F
STRAETMANS N
MICHAUX L
FERRANT A
JAMART J
MALGHEM J
MALDAGUE B
VANDEBERG B
Citation: F. Lecouvet et al., SPINAL BONE-MARROW MAGNETIC-RESONANCE-IMAGING (MRI) IN STAGE-III MULTIPLE-MYELOMA (MM) - CORRELATION WITH CLINICAL, LABORATORY AND HISTOLOGIC-FINDINGS, WITH INITIAL RESPONSE TO TREATMENT AND WITH PATIENT SURVIVAL, Blood, 90(10), 1997, pp. 1562-1562
Citation: N. Straetmans et al., EVOLUTION OF BONE-MARROW FIBROSIS AND STROMAL ANTIGENIC EXPRESSION INCHRONIC MYELOID-LEUKEMIA ON ALPHA-INTERFERON AND ARA-C THERAPY, Hematopathology and molecular hematology, 10(4), 1996, pp. 213-222
Authors:
VANDENNESTE E
DELANNOY A
VANDERCAM B
BOSLY A
FERRANT A
MINEUR P
MONTIFORT L
MARTIAT P
STRAETMANS N
FILLEUL B
MICHAUX JL
Citation: E. Vandenneste et al., INFECTIOUS COMPLICATIONS AFTER 2-CHLORODEOXYADENOSINE THERAPY, European journal of haematology, 56(4), 1996, pp. 235-240
Authors:
STRAETMANS N
HERMAN P
LAMMINEUR C
VANDENBERCHE H
FERRANT A
Citation: N. Straetmans et al., IN-VITRO STEM-CELL DEFECT IN REMISSION BONE-MARROW OF ACUTE MYELOID-LEUKEMIA, Experimental hematology, 24(9), 1996, pp. 67-67
Authors:
LAMMINEUR C
STRAETMANS N
HERMAN P
DENEYS V
BRICHARD B
COMU G
Citation: C. Lammineur et al., EX-VIVO EXPANSION OF HUMAN UMBILICAL-CORD BLOOD (HUCB) CD34+ CELLS INLIQUID CULTURE, Experimental hematology, 24(9), 1996, pp. 68-68
Authors:
HERMAN P
FERRANT A
VANDENBERGHE H
MICHAUX JL
STRAETMANS N
Citation: P. Herman et al., IN-VITRO EXPANSION OF CD34-MARROW OF ACUTE MYELOID-LEUKEMIA (AML) IN FIRST REMISSION(DR(LOW) CELLS FROM BONE), Blood, 88(10), 1996, pp. 3133-3133
Authors:
HERMAN P
FERRANT A
MICHAUX JL
DEBRUYERE M
STRAETMANS N
Citation: P. Herman et al., EX-VIVO EXPANSION OF NORMAL HUMAN BONE-MARROW CD34+DR(LOW) CELLS IN LIQUID CULTURE, Experimental hematology, 23(8), 1995, pp. 908-908
Authors:
FERRANT A
LATINNE D
BAZIN H
STRAETMANS N
CORNET A
DELAPARRA B
MICHAUX JL
Citation: A. Ferrant et al., PROPHYLAXIS OF GRAFT-VERSUS-HOST DISEASE IN IDENTICAL SIBLING DONOR BONE-MARROW TRANSPLANT BY ANTI-IL-2 RECEPTOR MONOCLONAL-ANTIBODY LO-TACT-1, Bone marrow transplantation, 16(4), 1995, pp. 577-581
Authors:
FERRANT A
DOYEN C
DELANNOY A
STRAETMANS N
MARTIAT P
MINEUR P
BOSLY A
VANDENBERGHE H
MICHAUX JL
Citation: A. Ferrant et al., KARYOTYPE IN ACUTE MYELOBLASTIC-LEUKEMIA - PROGNOSTIC-SIGNIFICANCE INA PROSPECTIVE-STUDY ASSESSING BONE-MARROW TRANSPLANTATION IN FIRST REMISSION, Bone marrow transplantation, 15(5), 1995, pp. 685-690
Authors:
STRAETMANS N
MA DDF
HERMAN P
ZENEBERGH A
CHANG A
DENEYS V
DEBRUYERE M
FERRANT A
Citation: N. Straetmans et al., LONG-TERM CULTURE OF AUTOLOGOUS TRANSPLANTED BONE-MARROW FOR ACUTE MYELOID-LEUKEMIA - EVIDENCE FOR AN IN-VITRO HEMATOPOIETIC DEFECT AND LACK OF CORRELATION WITH THE SPEED OF ENGRAFTMENT, Bone marrow transplantation, 15(3), 1995, pp. 421-428
Authors:
BOSLY A
SONET A
FERRANT A
DELANNOY A
CORNU G
CANON JL
MARTIAT P
STRAETMANS N
RAVOET C
MINEUR P
LASZLO C
JAMART J
DOYEN C
MICHAUX JL
Citation: A. Bosly et al., 2-CHLORODEOXYADENOSINE IN REFRACTORY NON-HODGKINS-LYMPHOMA - A PHASE-II STUDY ON 50 PATIENTS, Blood, 86(10), 1995, pp. 212-212
Authors:
STRAETMANS N
HERMAN P
ZENEBERGH A
DEBRUYERE M
FERRANT A
Citation: N. Straetmans et al., LONG-TERM CULTURE OF BONE-MARROW AUTOGRAFTS FOR ACUTE MYELOID-LEUKEMIA - IN-VITRO HEMATOPOIETIC DEFECT AND LACK OF CORRELATION WITH THE SPEED OF ENGRAFTMENT, Experimental hematology, 22(8), 1994, pp. 824-824
Authors:
FERRANT A
LATINNE D
BAZIN H
STRAETMANS N
CORNET A
DELAPARRA B
MICHAUX JL
Citation: A. Ferrant et al., PROPHYLAXIS OF GRAFT-VERSUS-HOST DISEASE IN IDENTICAL SIBLING DONOR BMT BY ANTI-IL-2 RECEPTOR MONOCLONAL-ANTIBODY LO-TACT-1, Blood, 84(10), 1994, pp. 10000158-10000158
Authors:
MARTIAT P
VANDAELE S
FERRANT A
STRAETMANS N
VANDENNESTE E
MAREVOET M
PHILIPPE M
VAERMAN JL
DEBRUYERE M
MICHAUX JL
Citation: P. Martiat et al., FREQUENT CONTAMINATION OF PBSC MOBILIZED USING CHEMOTHERAPY AND G-CSFIN INTERMEDIATE AND HIGH-GRADE LYMPHOMAS, EVEN WITHOUT BONE-MARROW INVOLVEMENT, Blood, 84(10), 1994, pp. 10000645-10000645
Authors:
VANDENNESTE E
MAEREVOET M
MARTIAT P
FERRANT A
DELANNOY A
STRAETMANS N
MICHAUX JL
Citation: E. Vandenneste et al., CYCLOSPORINE-A (CY A) HAS ONLY MARGINAL ANTILEUKEMIC ACTIVITY IN REFRACTORY CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL), Blood, 84(10), 1994, pp. 10000659-10000659